Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - AccuredRetained EarningsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CollPlant Biotechnologies (CLGN) Total Debt (2017 - 2021)

Historic Total Debt for CollPlant Biotechnologies (CLGN) over the last 5 years, with Q3 2021 value amounting to $5.7 million.

  • CollPlant Biotechnologies' Total Debt rose 45495.33% to $5.7 million in Q3 2021 from the same period last year, while for Sep 2021 it was $5.7 million, marking a year-over-year increase of 45495.33%. This contributed to the annual value of -$3.3 million for FY2020, which is 4385.76% up from last year.
  • CollPlant Biotechnologies' Total Debt amounted to $5.7 million in Q3 2021, which was up 45495.33% from $8.2 million recorded in Q2 2021.
  • In the past 5 years, CollPlant Biotechnologies' Total Debt registered a high of $17.8 million during Q1 2018, and its lowest value of -$5.9 million during Q4 2019.
  • Moreover, its 5-year median value for Total Debt was -$1.5 million (2020), whereas its average is $1.9 million.
  • As far as peak fluctuations go, CollPlant Biotechnologies' Total Debt plummeted by 16485.6% in 2018, and later soared by 86403.76% in 2021.
  • Over the past 5 years, CollPlant Biotechnologies' Total Debt (Quarter) stood at $3.6 million in 2017, then plummeted by 164.86% to -$2.4 million in 2018, then tumbled by 150.68% to -$5.9 million in 2019, then surged by 43.86% to -$3.3 million in 2020, then skyrocketed by 271.24% to $5.7 million in 2021.
  • Its last three reported values are $5.7 million in Q3 2021, $8.2 million for Q2 2021, and $10.6 million during Q1 2021.